| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/16/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 30k | $1.10 | $33k | | 12/16/2022 |
| 11/25/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 8.7k | $1.12 | $9.8k | | 11/25/2022 |
| 11/25/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 600 | $1.10 | $660 | | 11/25/2022 |
| 11/25/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 7k | $1.11 | $7.8k | | 11/25/2022 |
| 11/25/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 7k | $1.11 | $7.8k | Shares purchased though 401(k) plan | 11/25/2022 |
| 11/25/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 600 | $1.10 | $660 | Shares purchased though 401(k) plan | 11/25/2022 |
| 11/25/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock, par value $0.001 per share | 8.7k | $1.12 | $9.8k | Shares purchased though 401(k) plan | 11/25/2022 |
| 06/15/2021 | PDS Biotechnology Corp | EDGE | Purchase | Common Stock | 17.6k | $8.50 | $150k | | 06/15/2021 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Payment of Exercise | Common Stock | 45.3k | $1.00 | $45.3k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Payment of Exercise | Common Stock | 5.7k | $2.89 | $16.6k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Payment of Exercise | Common Stock | 4.7k | $3.11 | $14.5k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Exercise | Stock Option (right to buy) | 25k | $1.83 | $45.8k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Exercise | Stock Option (right to buy) | 30k | $1.06 | $31.8k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Exercise | Stock Option (right to buy) | 60.1k | $1.00 | $60.1k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Exercise | Stock Option (right to buy) | 20k | $2.89 | $57.8k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Exercise | Stock Option (right to buy) | 20k | $3.11 | $62.2k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Payment of Exercise | Common Stock | 13.7k | $1.83 | $25.1k | | 02/21/2020 |
| 02/21/2020 | RESEARCH FRONTIERS INC | REFR | Payment of Exercise | Common Stock | 22.2k | $1.06 | $23.5k | | 02/21/2020 |
| 12/31/2019 | RESEARCH FRONTIERS INC | REFR | Grant | Stock Option(right to buy) | 20k | $3.11 | $62.2k | | 12/31/2019 |
| 06/13/2019 | RESEARCH FRONTIERS INC | REFR | Grant | Stock Option(right to buy) | 20k | $2.89 | $57.8k | | 06/13/2019 |
| 05/03/2018 | RESEARCH FRONTIERS INC | REFR | Grant | Stock Option(right to buy) | 60.1k | $1.00 | $60.1k | | 05/03/2018 |
| 12/31/2017 | RESEARCH FRONTIERS INC | REFR | Grant | Stock Option(right to buy) | 30k | $1.06 | $31.8k | | 12/31/2017 |